(1-R,2-R,3-S,4-S,5-S,6-S)-5-ACETAMIDO-2,3,4-TRIBENZYLOXY-1-(BENZYLOXYMETHYL)-BICYCLO-[4.1.0]-HEPTANE
Compound with spectra: 1 NMR
![(1-R,2-R,3-S,4-S,5-S,6-S)-5-ACETAMIDO-2,3,4-TRIBENZYLOXY-1-(BENZYLOXYMETHYL)-BICYCLO-[4.1.0]-HEPTANE](/api/compound/LDrVXbBOLF2.png?ph=true&h=300&w=458 "(1-R,2-R,3-S,4-S,5-S,6-S)-5-ACETAMIDO-2,3,4-TRIBENZYLOXY-1-(BENZYLOXYMETHYL)-BICYCLO-[4.1.0]-HEPTANE")
| SpectraBase Compound ID | LDrVXbBOLF2 |
|---|---|
| InChI | InChI=1S/C38H41NO5/c1-28(40)39-34-33-22-38(33,27-41-23-29-14-6-2-7-15-29)37(44-26-32-20-12-5-13-21-32)36(43-25-31-18-10-4-11-19-31)35(34)42-24-30-16-8-3-9-17-30/h2-21,33-37H,22-27H2,1H3,(H,39,40)/t33-,34+,35+,36-,37+,38+/m1/s1 |
| InChIKey | SNILGZZCWDAVSM-AXOWIMNESA-N |
| Mol Weight | 591.7 g/mol |
| Molecular Formula | C38H41NO5 |
| Exact Mass | 591.298473 g/mol |
| Enantiomer InChIKey | SNILGZZCWDAVSM-CDQOGRMBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N,O-DICARBOTHIOATE_OF_VALIDAMINE
10,19-DIACETYL-SPHINXOLIDE;36-((E)-N-FORMYL-N-METHYLAMINO)-10,19-DIACETOXY-7,8,13,15,21,27,33-HEPTAMETHOXY-5,12,18,24,26,28,32-HEPTAMETHYL-31-OXO-11,9-(2-OXO-1
CIS-3-(3,4-DIMETHOXYPHENYL)-6-(FORMYLOXY)-5A-METHYL-1H,7H-5A,6,8,9-TETRAHYDRO-1-OXOPYRANO-[4.3-B]-[1]-BENZOPYRAN
TERT.-BUTYL-5-ACETAMIDO-2-C-(ACETOXYMETHYL)-2,6-ANHYDRO-4,7,8,9-TETRA-O-BENZYL-3,5-DIDESOXY-D-ERYTHRO-L-GLUCO-NONONATE
1-{[3-(dimethylamino)propyl]amino}-3-methyl-2-octylpyrido[1,2-a]benzimidazole-4-carbonitrile
#13;2-[2-[2-[2-(1,5-DIHYDRO-2,3,4-BENZODIOXAPHASPHONATO)-ETHOXY]-ETHOXY]-ETHYL]-6-O-(2-ACETAMIDO-3,4-DI-O-BENZYL-2-DEOXY-6-O-THEXYLDIMETHYLSILYL-5A-CARBA-ALPHA
Pertrimethylsilylated diflunisal glucuronide
1-(butylamino)-3-methyl-2-octylpyrido[1,2-a]benzimidazole-4-carbonitrile
Repandin A
| Title | Journal or Book | Year |
|---|---|---|
| A New Structural Motif for the Design of Potent Glucosidase Inhibitors | Journal of the American Chemical Society | 2001 |